CAMECO CORP

Explore how Cameco’s robust production, low debt, and strategic expansions position it for a uranium supply boom amid nuclear resurgence and regulatory shifts.

Strong 2025 results show Cameco’s resilience, but 2026 guidance tempts investors—learn how uranium demand, tech gains, and policy shifts shape its future.

Analyze Cameco’s 2025 earnings and uranium market trends, revealing why the Canadian producer’s robust profits amid rising nuclear demand and SMR opportunities keep it poised for long‑term growth.

Explore Came Co’s 2025 uranium earnings surge—$590M net profit, 200% EPS jump—plus why investors are cautious on 2026 production plans amid decarbonisation trends.

Explore Cameco’s 2025 earnings surge: revenue up 9%, EPS +27%, and a disciplined supply strategy amid market‑price uncertainty and geopolitical risks.

How Came Co. balances rising Kazakhstan output, tech upgrades and regulatory pushes to stay ahead in a volatile uranium market.

Discover why Cameco’s stock hit a 52‑week high amid rising demand for uranium, SMR tech, and supportive green‑energy policies, and what this means for investors.

Comeco surges to a 52‑week high after TD Securities upgrades its rating and lifts the price target, driving higher trading and options activity amid growing investor interest in uranium’s role in the energy transition.

Explore why Cameco’s uranium stock is surging amid AI‑fuelled energy demand, yet valuation concerns and high option activity signal a cautious buying strategy.

Institutional investors add modest stakes in Came Co., a top‑tier Canadian uranium producer, signaling confidence in its robust cash flow, long‑term contracts and Westinghouse partnership while highlighting regulatory risks and market dynamics.